中国医院用药评价与分析2025,Vol.25Issue(12):1421-1424,1429,5.DOI:10.14009/j.issn.1672-2124.2025.12.002
我国新生儿药学监护案例的质量分析及临床药师干预评估
Quality Analysis of Neonatal Pharmaceutical Care Cases and Evaluation of Clinical Pharmacist Intervention in China
摘要
Abstract
OBJECTIVE:To analyze the pharmaceutical care cases of Neonatology in China by case report guideline(CARE),and to provide reference for the establishment of evaluation system of clinical pharmaceutical case analysis in Neonatology.METHODS:Two clinical pharmacists searched databases such as CNKI and Wanfang Data with keywords(from database establishment to Nov.16th,2024),and included the cases by checking the title,abstract and full text.The quality of included pharmaceutical care cases of Neonatology were evaluated according to CARE,and the disease types and intervention methods of included cases were analyzed.RESULTS:Forty-three cases of neonatal pharmaceutical care cases were finally included through searching and screening of clinical pharmacists,and review of superior pharmacists.The overall CARE score was(20.65±2.08)points;29 cases related to premature infants,with the average CARE score of(20.27±1.79)points;33 cases related to neonatal infectious diseases,with the average CARE score of(20.85±2.17)points.Clinical pharmacists intervened by increasing the drugs and optimizing the treatment regimen.In neonatal pharmaceutical care cases,the scores were low on the description of main symptoms or clinical characteristics in abstract,follow-up and prognosis,and informed consent.CONCLUSIONS:The pharmaceutical care cases of Neonatology could be effectively evaluated with the CARE,which could provide reference for further improving the ability of pharmaceutical care and the quality of clinical service of neonatal clinical pharmacists.关键词
新生儿科/药学监护/案例评估工具/评估系统建设/临床药师干预Key words
Neonatology/Pharmaceutical care/Case report guideline/Evaluation system/Intervention of clinical pharmacists分类
医药卫生引用本文复制引用
LI Jiahui,WANG Ran,WANG Aihua,ZHANG Xueyan,DU Boran,FENG Xin..我国新生儿药学监护案例的质量分析及临床药师干预评估[J].中国医院用药评价与分析,2025,25(12):1421-1424,1429,5.基金项目
国家自然科学基金青年项目(No.72204170) (No.72204170)
首都卫生发展专项(No.首发2024-2-2115) (No.首发2024-2-2115)
北京市医院管理中心临床医学专项经费资助(No.ZYLX202119) (No.ZYLX202119)
北京市属医院科研培育项目(No.PZ2021028) (No.PZ2021028)
中国药学会医院药学专业委员会医院药学科研专项资助项目(No.CPA-Z05-ZC-2022-002) (No.CPA-Z05-ZC-2022-002)
中华医学会临床药学分会2023年度临床药学青年项目(No.Z-2021-46-2101-2023) (No.Z-2021-46-2101-2023)